Nationwide Fund Advisors’s Adverum Biotechnologies ADVM Stock Holding History

Nationwide Fund Advisors’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,624	Closed	-$44K	–	3202
2017 Q1	$44K	Sell	1,624 -20	-1%	-$569	﹤0.01%	3001
2016 Q4	$48K	Hold	1,644	–	–	﹤0.01%	3005
2016 Q3	$68K	Buy	1,644 +209	+15%	+$7.93K	﹤0.01%	2996
2016 Q2	$45K	Hold	1,435	–	–	﹤0.01%	3089
2016 Q1	$74K	Hold	1,435	–	–	﹤0.01%	2903
2015 Q4	$137K	Hold	1,435	–	–	﹤0.01%	2725
2015 Q3	$118K	Sell	1,435 -40	-3%	-$5.11K	﹤0.01%	2829
2015 Q2	$240K	Sell	1,475 -261	-15%	-$88.1K	﹤0.01%	2611
2015 Q1	$703K	Buy	1,736 +689	+66%	+$291K	﹤0.01%	2080
2014 Q4	$565K	Buy	1,047 +310	+42%	+$119K	﹤0.01%	2110
2014 Q3	$252K	Buy	+737	New	+$219K	﹤0.01%	2584

Other funds holding ADVM

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nationwide Fund Advisors's ADVM Position: Q2 2017 in Review

Nationwide Fund Advisors sold out of Adverum Biotechnologies (ADVM) in Q2 2017, closing a stake of 1,624 shares — an estimated $44K sold.

Nationwide Fund Advisors first reported a position in ADVM in Q3 2014 and held it in 11 quarters. The position peaked at $703K in Q1 2015. 63 funds tracked by Wall St. Rank hold ADVM as of Q2 2017.

Nationwide Fund Advisors reported no remaining Adverum Biotechnologies position as of Q2 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 1,624 Adverum Biotechnologies shares in Q2 2017, an estimated $44K.
Nationwide Fund Advisors first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 11 quarters.
Nationwide Fund Advisors's Adverum Biotechnologies position peaked at $703K in Q1 2015.
63 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2017.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.